Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson`s Disease. β
Go to Publication β
Frontiers in neuroscience (Front Neurosci ) Vol: 14 Issue Pages: 549037 Pub: 2020 Epub: 2020 Dec 14 Authors Chen TJ , Feng Y , Liu T , Wu TT , Chen YJ , Li X , Li Q , Wu YC , |
|
|
Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson`s Disease. β
Go to Publication β
Frontiers in neuroscience (Front Neurosci ) Vol: 14 Issue Pages: 549037 Pub: 2020 Epub: 2020 Dec 14 Authors Chen TJ , Feng Y , Liu T , Wu TT , Chen YJ , Li X , Li Q , Wu YC , |
|
|
Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson`s Disease. β
Go to Publication β
Frontiers in neuroscience (Front Neurosci ) Vol: 14 Issue Pages: 549037 Pub: 2020 Epub: 2020 Dec 14 Authors Chen TJ , Feng Y , Liu T , Wu TT , Chen YJ , Li X , Li Q , Wu YC , |
|
|
Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson`s Disease. β
Go to Publication β
Frontiers in neuroscience (Front Neurosci ) Vol: 14 Issue Pages: 549037 Pub: 2020 Epub: 2020 Dec 14 Authors Chen TJ , Feng Y , Liu T , Wu TT , Chen YJ , Li X , Li Q , Wu YC , |
|
|
Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson`s Disease. β
Go to Publication β
Frontiers in neuroscience (Front Neurosci ) Vol: 14 Issue Pages: 549037 Pub: 2020 Epub: 2020 Dec 14 Authors Chen TJ , Feng Y , Liu T , Wu TT , Chen YJ , Li X , Li Q , Wu YC , |
|
|
Fisetin regulates gut microbiota to decrease CCR9+/CXCR3+/CD4+ T-lymphocyte count and IL-12 secretion to alleviate premature ovarian failure in mice. β
American journal of translational research (Am J Transl Res ) Vol: 12 Issue 1 Pages: 203-247 Pub: 2020 Epub: 2020 Jan 15 Authors Lin J , Nie X , Xiong Y , Gong Z , Chen J , Chen C , Huang Y , Liu T , |
|
|
Fisetin regulates gut microbiota to decrease CCR9+/CXCR3+/CD4+ T-lymphocyte count and IL-12 secretion to alleviate premature ovarian failure in mice. β
American journal of translational research (Am J Transl Res ) Vol: 12 Issue 1 Pages: 203-247 Pub: 2020 Epub: 2020 Jan 15 Authors Lin J , Nie X , Xiong Y , Gong Z , Chen J , Chen C , Huang Y , Liu T , |
|
|
Fisetin regulates gut microbiota to decrease CCR9+/CXCR3+/CD4+ T-lymphocyte count and IL-12 secretion to alleviate premature ovarian failure in mice. β
American journal of translational research (Am J Transl Res ) Vol: 12 Issue 1 Pages: 203-247 Pub: 2020 Epub: 2020 Jan 15 Authors Lin J , Nie X , Xiong Y , Gong Z , Chen J , Chen C , Huang Y , Liu T , |
|
|
Fisetin modulates the gut microbiota alongside biomarkers of senescence and inflammation in a DSS-induced murine model of colitis. β
Go to Publication β
GeroScience (Geroscience ) Vol: 46 Issue 3 Pages: 3085-3103 Pub: 2024 Jun Epub: 2024 Jan 8 Authors Ashiqueali SA , Chaudhari D , Zhu X , Noureddine S , Siddiqi S , Garcia DN , Gostynska A , Stawny M , Rubis B , Zanini BM , Mansoor MAM , Schneider A , Naser SA , Yadav H , Masternak MM , |
|
|
Luteolin and fisetin inhibit the effects of lipopolysaccharide obtained from Porphyromonas gingivalis in human gingival fibroblasts. β
Go to Publication β
Molecular biology reports (Mol Biol Rep ) Vol: 40 Issue 1 Pages: 477-85 Pub: 2013 Jan Epub: 2012 Oct 11 Authors Gutiérrez-Venegas G , Contreras-Sánchez A , |
|
|
Association of polyphenols from oranges and apples with specific intestinal microorganisms in systemic lupus erythematosus patients. β
Go to Publication β
Nutrients (Nutrients ) Vol: 7 Issue 2 Pages: 1301-17 Pub: 2015 Feb 16 Epub: 2015 Feb 16 Authors Cuervo A , Hevia A , López P , Suárez A , Sánchez B , Margolles A , González S , |
|
|
The prebiotic potential of dietary onion extracts: shaping gut microbial structures and promoting beneficial metabolites. β
Go to Publication β
mSystems (mSystems ) Vol: 10 Issue 1 Pages: e0118924 Pub: 2025 Jan 21 Epub: 2024 Dec 23 Authors Yoo Y , Kim S , Lee W , Kim J , Son B , Lee KJ , Shin H , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
